LL-37 5mg (CAP-18)
Research Studies:
- Facilitates analysis of hCAP-18 proteolytic cleavage into biologically active LL-37
- Supports investigation of FPR2-mediated chemotaxis and pro-inflammatory signaling in leukocytes
- Enables research on membrane permeabilization mechanisms within multidrug-resistant bacterial assays
- Useful for evaluating P2X7 receptor activation and NLRP3 inflammasome assembly